Sjukdomar i Onco Wiki
OpenOnco-täckning på 103 onkologiska diagnoser: biomarkörer, droger, indikationer/nyheter/RedFlags, algoritm och frågeformulär närvaro, fyll och valfritt registrerad innehåll-review bevis.
Metriska definitioner
- #Bio — särskiljande biomarkörer som hänvisas till denna sjukdoms indikationer + regler
- #Drug — olika läkemedel i denna sjukdoms regim
- #Ind / # Reg / #RF — Indikationer / Regimens / RedFlags för denna sjukdom
- 1L / 2L — Algorithm presence for first-line / second-line+
- Sök — handanmäld/framkallad av STUB/
- Fyll i % — komposit över 8 enheters typer: ≥1 indikation, ≥1 regim, ≥ 1 biomarkör, ≥1-läkemedel, ≥1, rödflag, 1L algo, frågeformulär, upparbetning
- Ver % — % of this disease's indications with reviewer_signoffs ≥ 2 (CHARTER §6.1)
Solo-projektet. En underhållare levererar uppdateringar med automatiska kontroller och källspårbarhet. Extern klinisk granskning är valfri och registreras separat.
Totalt antal sjukdomar
103
Fyld med medelvärde
69.8%
Med 1L-algoritme
87/103
Med 2L+-algoritme
55/103
103
No diseases match your search.
Sjukdomstäckning
Lymfoid hematologisk (28)
| Sjukdom | ICD-10 | Bio | Drog | Ind | Reg. | RF | 1L | 2L | Sök | Fyll i % | Ver % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATLL Adult T-Cell Leukemia/Lymphoma | C91.5 | 1 | 9 | 5 | 3 | 8 | ✓ | ✓ | — | 88% | 0% |
| ALCL Anaplastic Large Cell Lymphoma, Systemic | C84.6 | 2 | 6 | 5 | 5 | 5 | ✓ | ✓ | — | 88% | 0% |
| AITL Angioimmunoblastic T-Cell Lymphoma | C84.4 | 2 | 9 | 5 | 5 | 8 | ✓ | ✓ | — | 88% | 0% |
| B-ALL B-Lymphoblastic Leukemia/Lymphoma | C91.0 | 1 | 14 | 8 | 5 | 9 | ✓ | ✓ | — | 88% | 0% |
| BURKITT Burkitt Lymphoma | C83.7 | 3 | 15 | 10 | 6 | 10 | ✓ | ✓ | — | 88% | 0% |
| CLL Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma | C91.1 | 5 | 7 | 8 | 6 | 13 | ✓ | ✓ | ✓ | 88% | 0% |
| CHL Classical Hodgkin Lymphoma | C81.9 | 3 | 7 | 7 | 5 | 6 | ✓ | ✓ | — | 88% | 0% |
| DLBCL-NOS Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | C83.3 | 8 | 15 | 26 | 10 | 23 | ✓ | ✓ | — | 88% | 0% |
| NK-T-NASAL Extranodal NK/T-Cell Lymphoma, Nasal Type | C86.0 | 1 | 8 | 3 | 3 | 5 | ✓ | ✓ | — | 88% | 0% |
| FL Follicular Lymphoma | C82.0 | 3 | 12 | 9 | 8 | 9 | ✓ | ✓ | — | 88% | 0% |
| HCV-MZL HCV-associated Marginal Zone Lymphoma | C88.4 | 1 | 3 | 7 | 3 | 7 | ✓ | ✓ | ✓ | 88% | 0% |
| HGBL-DH High-Grade B-Cell Lymphoma, Double-Hit / Triple-Hit | C83.3 | 5 | 8 | 3 | 3 | 7 | ✓ | ✓ | — | 88% | 0% |
| MCL Mantle Cell Lymphoma | C83.1 | 5 | 12 | 7 | 6 | 9 | ✓ | ✓ | — | 88% | 0% |
| MM Multiple Myeloma | C90.0 | 2 | 13 | 16 | 13 | 14 | ✓ | ✓ | ✓ | 88% | 0% |
| MF-SEZARY Mycosis Fungoides / Sézary Syndrome | C84.0 | 1 | 3 | 5 | 4 | 5 | ✓ | ✓ | — | 88% | 0% |
| NODAL-MZL Nodal Marginal Zone Lymphoma | C83.0 | 3 | 3 | 4 | 3 | 5 | ✓ | ✓ | — | 88% | 0% |
| NLPBL Nodular Lymphocyte-Predominant B-cell Lymphoma | C81.0 | 1 | 5 | 3 | 2 | 6 | ✓ | ✓ | — | 88% | 0% |
| PTLD Post-Transplant Lymphoproliferative Disorder | D47.Z1 | 3 | 5 | 3 | 3 | 6 | ✓ | ✓ | — | 88% | 0% |
| PCNSL Primary CNS Lymphoma | C85.7 | 1 | 6 | 3 | 3 | 6 | ✓ | ✓ | — | 88% | 0% |
| PMBCL Primary Mediastinal Large B-Cell Lymphoma | C85.2 | 1 | 8 | 3 | 3 | 8 | ✓ | ✓ | — | 88% | 0% |
| SPLENIC-MZL Splenic Marginal Zone Lymphoma | C83.0 | 3 | 3 | 3 | 3 | 5 | ✓ | ✓ | — | 88% | 0% |
| T-PLL T-Cell Prolymphocytic Leukemia | C91.6 | 1 | 2 | 2 | 2 | 5 | ✓ | ✓ | — | 88% | 0% |
| WM Waldenström Macroglobulinemia / Lymphoplasmacytic Lymphoma | C88.0 | 2 | 6 | 5 | 5 | 7 | ✓ | ✓ | — | 88% | 0% |
| EATL Enteropathy-Associated T-Cell Lymphoma | C86.2 | 0 | 7 | 4 | 2 | 6 | ✓ | — | — | 75% | 0% |
| HCL Hairy Cell Leukemia | C91.4 | 0 | 2 | 3 | 2 | 5 | ✓ | ✓ | — | 75% | 0% |
| HSTCL Hepatosplenic T-Cell Lymphoma | C84.7 | 0 | 7 | 2 | 2 | 6 | ✓ | — | — | 75% | 0% |
| PTCL-NOS Peripheral T-Cell Lymphoma, NOS | C84.4 | 0 | 8 | 4 | 4 | 5 | ✓ | ✓ | — | 75% | 0% |
| T-ALL T-Lymphoblastic Leukemia/Lymphoma | C91.0 | 0 | 9 | 2 | 2 | 9 | ✓ | ✓ | — | 75% | 0% |
| avg | 85.7% | 0.0% | |||||||||
Myeloid hematologisk (9)
| Sjukdom | ICD-10 | Bio | Drog | Ind | Reg. | RF | 1L | 2L | Sök | Fyll i % | Ver % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AML Acute Myeloid Leukemia | C92.0 | 4 | 13 | 39 | 10 | 37 | ✓ | ✓ | — | 88% | 0% |
| MASTOCYTOSIS Advanced systemic mastocytosis | C96.2, D47.09 | 1 | 2 | 2 | 2 | 6 | ✓ | — | — | 88% | 0% |
| PV Polycythemia Vera | D45 | 1 | 5 | 6 | 4 | 6 | ✓ | ✓ | — | 88% | 0% |
| APL Acute Promyelocytic Leukemia | C92.4 | 0 | 4 | 4 | 4 | 9 | ✓ | ✓ | — | 75% | 0% |
| CML Chronic Myeloid Leukemia | C92.1 | 0 | 7 | 5 | 5 | 9 | ✓ | ✓ | — | 75% | 0% |
| ET Essential Thrombocythemia | D47.3 | 0 | 3 | 3 | 2 | 7 | ✓ | ✓ | — | 75% | 0% |
| MDS-HR Myelodysplastic Syndromes — Higher Risk | D46.2 | 0 | 2 | 7 | 3 | 15 | ✓ | ✓ | — | 75% | 0% |
| MDS-LR Myelodysplastic Syndromes — Lower Risk | D46.9 | 0 | 4 | 4 | 4 | 9 | ✓ | ✓ | — | 75% | 0% |
| PMF Primary Myelofibrosis | D47.4 | 0 | 3 | 5 | 4 | 7 | ✓ | ✓ | — | 75% | 0% |
| avg | 79.3% | 0.0% | |||||||||
Solid tumörer (66)
| Sjukdom | ICD-10 | Bio | Drog | Ind | Reg. | RF | 1L | 2L | Sök | Fyll i % | Ver % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| THYROID-ANAPLASTIC Anaplastic thyroid carcinoma | C73 | 1 | 4 | 2 | 2 | 7 | ✓ | — | — | 88% | 0% |
| BCC Basal cell carcinoma | C44 | 2 | 2 | 4 | 2 | 8 | ✓ | — | — | 88% | 0% |
| CERVICAL Cervical carcinoma | C53 | 2 | 7 | 9 | 4 | 17 | ✓ | — | — | 88% | 0% |
| CHOLANGIOCARCINOMA Cholangiocarcinoma | C22.1, C24.0 | 3 | 9 | 12 | 8 | 10 | ✓ | ✓ | — | 88% | 0% |
| CRC Colorectal carcinoma | C18-C20 | 5 | 16 | 75 | 15 | 43 | ✓ | ✓ | — | 88% | 0% |
| MELANOMA Cutaneous melanoma | C43 | 2 | 12 | 15 | 8 | 19 | ✓ | ✓ | — | 88% | 0% |
| ENDOMETRIAL Endometrial carcinoma | C54 | 2 | 5 | 9 | 4 | 23 | ✓ | ✓ | — | 88% | 0% |
| ESOPHAGEAL Esophageal carcinoma | C15 | 3 | 13 | 19 | 10 | 15 | ✓ | ✓ | — | 88% | 0% |
| GI-NET GI neuroendocrine tumor (carcinoid) | C17.9 | 1 | 1 | 1 | 1 | 6 | ✓ | — | — | 88% | 0% |
| GASTRIC Gastric and gastroesophageal junction adenocarcinoma | C16 | 5 | 18 | 19 | 9 | 25 | ✓ | ✓ | — | 88% | 0% |
| GIST Gastrointestinal stromal tumor | C49 | 2 | 4 | 4 | 4 | 6 | ✓ | ✓ | — | 88% | 0% |
| GBM Glioblastoma | C71 | 2 | 2 | 6 | 4 | 8 | ✓ | ✓ | — | 88% | 0% |
| HNSCC Head and neck squamous cell carcinoma | C00-C14, C30-C32 | 1 | 6 | 9 | 5 | 9 | ✓ | ✓ | — | 88% | 0% |
| HCC Hepatocellular carcinoma | C22.0 | 4 | 10 | 32 | 8 | 23 | ✓ | ✓ | — | 88% | 0% |
| IFS Infantile fibrosarcoma | C49 | 1 | 1 | 1 | 1 | 5 | ✓ | — | — | 88% | 0% |
| IMT Inflammatory myofibroblastic tumor | D48.1 | 1 | 1 | 1 | 1 | 5 | ✓ | — | — | 88% | 0% |
| BREAST Invasive breast cancer | C50 | 11 | 26 | 84 | 19 | 65 | ✓ | ✓ | — | 88% | 0% |
| GLIOMA-LOW-GRADE Low-grade glioma | C71 | 1 | 3 | 9 | 1 | 11 | ✓ | — | — | 88% | 0% |
| LAM Lymphangioleiomyomatosis | J84.81 | 1 | 1 | 1 | 1 | 1 | ✓ | — | — | 88% | 0% |
| MTC Medullary thyroid carcinoma | C73 | 1 | 2 | 6 | 2 | 8 | ✓ | — | — | 88% | 0% |
| NSCLC Non-small cell lung cancer | C34 | 19 | 32 | 77 | 30 | 44 | ✓ | ✓ | — | 88% | 0% |
| OVARIAN Ovarian carcinoma | C56 | 4 | 11 | 25 | 11 | 34 | ✓ | ✓ | — | 88% | 0% |
| PDAC Pancreatic ductal adenocarcinoma | C25 | 1 | 9 | 18 | 5 | 36 | ✓ | ✓ | — | 88% | 0% |
| PNET Pancreatic neuroendocrine tumor | C25.4 | 1 | 1 | 7 | 1 | 5 | ✓ | — | — | 88% | 0% |
| PROSTATE Prostate adenocarcinoma | C61 | 4 | 10 | 9 | 8 | 27 | ✓ | ✓ | — | 88% | 0% |
| RCC Renal cell carcinoma | C64 | 1 | 7 | 27 | 7 | 23 | ✓ | ✓ | — | 88% | 0% |
| UROTHELIAL Urothelial carcinoma | C67 | 1 | 6 | 16 | 6 | 20 | ✓ | ✓ | — | 88% | 0% |
| GRANULOSA-CELL Adult granulosa cell tumor | C56 | 1 | 2 | 1 | 1 | 0 | ✓ | — | — | 75% | 0% |
| ANAL-SCC Anal squamous cell carcinoma (Anal SCC) | C21.0 | 0 | 5 | 3 | 3 | 2 | ✓ | — | — | 75% | 0% |
| CHONDROSARCOMA Chondrosarcoma | C40, C41 | 0 | 1 | 1 | 1 | 5 | ✓ | — | — | 75% | 0% |
| EPITHELIOID-SARCOMA Epithelioid sarcoma | C49 | 1 | 1 | 1 | 1 | 0 | ✓ | — | — | 75% | 0% |
| KAPOSI Kaposi sarcoma | C46 | 1 | 4 | 11 | 4 | 4 | ✓ | — | — | 75% | 0% |
| LARYNGEAL Laryngeal squamous cell carcinoma | C32 | 1 | 5 | 7 | 4 | 1 | ✓ | — | — | 75% | 0% |
| MESOTHELIOMA Malignant mesothelioma | C45.0 | 0 | 4 | 5 | 3 | 5 | ✓ | ✓ | — | 75% | 0% |
| MPNST Malignant peripheral nerve sheath tumor | C47 | 0 | 2 | 1 | 1 | 6 | ✓ | — | — | 75% | 0% |
| THYROID-PAPILLARY Papillary thyroid carcinoma | C73 | 0 | 1 | 3 | 1 | 10 | ✓ | — | — | 75% | 0% |
| PARATHYROID-CARCINOMA Parathyroid carcinoma | C75.0 | 2 | 2 | 3 | 2 | 1 | ✓ | — | — | 75% | 0% |
| PENILE-SCC Penile squamous cell carcinoma | C60 | 1 | 5 | 5 | 3 | 1 | ✓ | — | — | 75% | 0% |
| PITUITARY-ADENOMA Pituitary adenoma | D35.2 | 1 | 3 | 4 | 3 | 1 | ✓ | — | — | 75% | 0% |
| SALIVARY Salivary gland carcinoma | C07, C08 | 0 | 2 | 1 | 1 | 6 | ✓ | — | — | 75% | 0% |
| SCLC Small cell lung cancer | C34 | 0 | 7 | 7 | 7 | 16 | ✓ | ✓ | — | 75% | 0% |
| SOFT-TISSUE-SARCOMA Soft tissue sarcoma | C49.9 | 0 | 6 | 10 | 4 | 8 | ✓ | ✓ | — | 75% | 0% |
| TGCT Tenosynovial giant cell tumor | M12.2 | 1 | 1 | 1 | 1 | 0 | ✓ | — | — | 75% | 0% |
| TESTICULAR-GCT Testicular germ cell tumor | C62.9 | 2 | 5 | 4 | 3 | 0 | ✓ | ✓ | — | 75% | 0% |
| VULVAR-VAGINAL-SCC Vulvar and vaginal squamous cell carcinoma | C51, C52 | 1 | 2 | 5 | 2 | 3 | ✓ | — | — | 75% | 0% |
| ADRENOCORTICAL-CARCINOMA Adrenocortical carcinoma | C74.0 | 0 | 4 | 2 | 2 | 2 | ✓ | — | — | 62% | 0% |
| NPC Nasopharyngeal carcinoma | C11 | 0 | 3 | 2 | 2 | 1 | ✓ | — | — | 62% | 0% |
| PHEOCHROMOCYTOMA Pheochromocytoma | D35.0 | 0 | 4 | 14 | 4 | 9 | ✓ | — | — | 62% | 0% |
| JMML Juvenile myelomonocytic leukemia | C93.3 | 0 | 0 | 1 | 1 | 0 | ✓ | — | — | 50% | 0% |
| MENINGIOMA Meningioma | D32 | 0 | 0 | 1 | 0 | 1 | ✓ | — | — | 50% | 0% |
| OSTEOSARCOMA Osteosarcoma | C40, C41 | 0 | 0 | 2 | 0 | 4 | — | — | — | 25% | 0% |
| WILMS Wilms tumor | C64 | 0 | 0 | 2 | 0 | 2 | — | — | — | 25% | 0% |
| LEIOMYOSARCOMA Leiomyosarcoma | C49, C54.2 | 0 | 0 | 0 | 0 | 2 | — | — | — | 12% | 0% |
| ATRT Atypical teratoid/rhabdoid tumor | C71.9 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| CHOROID-PLEXUS-CARCINOMA Choroid plexus carcinoma | C71.5 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| CYSTIC-NEPHROMA Cystic nephroma | D30.0 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| HEPATOBLASTOMA Hepatoblastoma | C22.2 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| MEDULLOBLASTOMA Medulloblastoma | C71.6 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| NEUROBLASTOMA Neuroblastoma | C74.9 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PARAGANGLIOMA Paraganglioma | D44.7 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PINEOBLASTOMA Pineoblastoma | C75.3 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PITUITARY-BLASTOMA Pituitary blastoma | C75.1 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PLEUROPULMONARY-BLASTOMA Pleuropulmonary blastoma | C34 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| RETINOBLASTOMA Retinoblastoma | C69.2 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| RHABDOMYOSARCOMA Rhabdomyosarcoma | C49.9 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| SERTOLI-LEYDIG-OVARIAN Sertoli-Leydig cell tumor | C56 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| avg | 61.7% | 0.0% | |||||||||